Expression and Localization of E-Cadherin in Epithelial Ovarian Cancer

被引:0
作者
Koensgen, Dominique [2 ]
Freitag, Cornelia [1 ]
Klaman, Irina [3 ]
Dahl, Edgar [4 ]
Mustea, Alexander [2 ]
Chekerov, Radoslav [1 ]
Braicu, Ioana [1 ]
Lichtenegger, Werner [1 ]
Sehouli, Jalid [1 ]
机构
[1] Charite, Campus Virchow Clin, Dept Gynecol, D-13353 Berlin, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Hosp Greifswald, Dept Gynecol & Obstet, D-17475 Greifswald, Germany
[3] Signature Diagnost AG, D-14469 Potsdam, Germany
[4] Univ Hosp, Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany
关键词
E-Cadherin; ovarian cancer; expression; prognosis; CELL-ADHESION; SURFACE EPITHELIUM; BETA-CATENIN; CARCINOMAS; PROGRESSION; RECEPTORS; TUMORS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Findings for the role of E-cadherin in ovarian cancer (OC) are controversial. The aim of this study was to analyze the expression and prognostic role of E-cadherin in OC. Materials and Methods: Expression analysis of E-cadherin was performed by immunohistochemistry in 36 patients (12 primary OC, 15 recurrent OC, 9 benign ovarian lesions). Tumor specimens were collected within OC. Correlation analysis with clinicopathological factors and survival was performed. Results: E-Cadherin was significantly reduced in OC compared to benign ovarian lesions (p=0.024). In primary OC, E-cadherin was comparable in ovarian tumor and corresponding metastatic tumor tissue. E-Cadherin showed no association with clinicopathological factors. A significant correlation between increased volume of ascites and higher E-cadherin immunoexpression was found in primary OC (p=0.029). E-Cadherin expression showed no statistically prognostic significance for survival (p=0.856). Conclusion: The function of E-cadherin in OC remains controversial and needs to be elucidated further in larger studies.
引用
收藏
页码:2525 / 2530
页数:6
相关论文
共 21 条
[1]  
Aplin AE, 1998, PHARMACOL REV, V50, P197
[2]   CADHERIN EXPRESSION IN CARCINOMAS - ROLE IN THE FORMATION OF CELL-JUNCTIONS AND THE PREVENTION OF INVASIVENESS [J].
BIRCHMEIER, W ;
BEHRENS, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :11-26
[3]  
Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123
[4]   Long-term results and prognostic factors in patients with epithelial ovarian cancer [J].
Brun, JL ;
Feyler, A ;
Chêne, G ;
Saurel, J ;
Brun, G ;
Hocké, C .
GYNECOLOGIC ONCOLOGY, 2000, 78 (01) :21-27
[5]   The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene [J].
Christofori, G ;
Semb, H .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :73-76
[6]   Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases [J].
Darai, E ;
Scoazec, JY ;
WalkerCombrouze, F ;
MlikaCabanne, N ;
Feldmann, G ;
Madelenat, P ;
Potet, F .
HUMAN PATHOLOGY, 1997, 28 (08) :922-928
[7]   Association of E-cadherin and β-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas [J].
Faleiro-Rodrigues, C ;
Macedo-Pinto, I ;
Pereira, D ;
Ferreira, VM ;
Lopes, CS .
HUMAN PATHOLOGY, 2004, 35 (06) :663-669
[8]  
Fujioka T, 2001, ONCOL REP, V8, P249
[9]   AN IN-VITRO MODEL OF OVARIAN EPITHELIAL CARCINOGENESIS - CHANGES IN CELL-CELL COMMUNICATION AND ADHESION OCCURRING DURING NEOPLASTIC PROGRESSION [J].
HOFFMAN, AG ;
BURGHARDT, RC ;
TILLEY, R ;
AUERSPERG, N .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (05) :828-838
[10]   Elevated expression of E-cadherin and α-, and γ-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas [J].
Imai, T ;
Horiuchi, A ;
Shiozawa, T ;
Osada, R ;
Kikuchi, N ;
Ohira, S ;
Oka, K ;
Konishi, I .
HUMAN PATHOLOGY, 2004, 35 (12) :1469-1476